Page 3 - Private Financing News Today

Georgia Bio Awards 2021 Golden Helix to VERO Biotech for Best Deal of the Year PR Newswire VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that the company was awarded the coveted Golden Helix "Best Deal of the Year" Award for 2021 by Georgia Bio, the states life science trade association. VERO Biotech was recognized in the category of Private Financing, in a virtual ...

A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University A Liberian Scholar Graduates With Two Distinct Masters from University of Kigali and Mount Kenya University Share A Kigali-based Liberian scholar, Amara M. Kamara, recently graduated with two masters, an MSc in Project Management from the University of Kigali and an MA in Development Studies from Mount Kenya University, Kenya.  Amara, famous as the Kigali trained, ably represented Liberi...

Share this article LA JOLLA, Calif., March 9, 2021 /PRNewswire/ --  Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today reported financial results for the fourth quarter and year ended December 31, 2020 and provided a corporate update.  "Regulus finished the year on a high note", stated Jay Hagan, CEO of Regulus. "We advanced RGLS4326 into a Phase 1b stu...

Eve & Co Announces CAD$1M Private Financing December 30, 2020 17:36 ET | Source: Eve & Co Incorporated Eve & Co Incorporated Strathroy, Ontario, CANADA STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that its wholly-owned subsidiary Natural MedCo Ltd (“NMC”) has entered into a CAD$1M financing loan with a private consortium of lenders (the “...

A proposal to build an aerial tram system in downtown Long Beach will likely move forward early next year, as the developers behind the idea say they have secured private funding to conduct an initial study. Clay Sandidge, a co-developer for the project, which has been dubbed “The Wave,” said in a phone interview this week that his team expects to begin a feasibility study and cost-benefit analysis by the end of March. The study will cost an estimated $500,000 and likely take 60-to-90...